Colorado State Board of Pharmacy

Pharmacy HOME

Welcome to the Pharmacy Homepage

The Colorado State Board of Pharmacy regulates pharmacists, pharmacy interns, pharmacy technicians, in-state and nonresident pharmacies, in-state and out-of-state prescription drug wholesalers, satellite pharmacies, specialized prescription drug outlets, other outlets, and limited licenses. The Board upholds consumer protection by licensing qualified applicants, investigating complaints, and enforcing disciplinary actions against violators of the Pharmacists, Pharmacy Business and Pharmaceuticals Act and the Board's rules.

The Board consists of five pharmacist members and two public members and works in conjunction with the Federal Food and Drug Administration (FDA), Drug Enforcement Administration (DEA), Colorado Pharmacists Society, RxPlus Pharmacies, and the Colorado Retail Council.

Program Information

Program/Board Members

Dmitry Kunin, Senior Program Director

State Board of Pharmacy 
1560 Broadway, Suite 1350
Denver, CO 80202

Phone: 303-894-7800  |  Fax: 303-894-7692  |  Email:


Board Members:

  • James Hansen, RPh, MBA, President
    Term Expires: July 1, 2023

  • Avani Soni, Pharm.D., RPh, Vice President
    Term Expires: July 1, 2025

  • Kristen Wolf, PharmD, BCSCP
    Term Expires: July 1, 2023

  • Patricia A.Evacko, PharmD.
    Term Expires: July 1, 2026

  • Eric Frazer, Pharm.D.
    Term Expires: July 1, 2025

  • Casey Frank, JD, MPH
    Term Expires: July 1, 2023

  • Brian C. Gonzales, MSW, LCSW, LAC
    Term Expires: July 1, 2023

Public Notices

Emergency and Permanent Rulemaking Hearing - September 29, 2022

The State Board of Pharmacy will hold an Emergency and Permanent Rulemaking Hearing to allow stakeholders a final opportunity to provide testimony before the Board considers adopting multiple proposed new and revised rules to implement stakeholder recommendations, new legislation, and executive orders. The Board will consider all proposed rules on a permanent basis, and in addition, will consider emergency adoption of new Rules 32.00.00 and 33.00.00 to fulfill the 90-day reporting requirements of the Executive Orders. The proposed rules based on stakeholder recommendations include the following topics: third-party logistics providers, reporting requirements, collaborative practice agreements, Appendix A, Appendix C, and Appendix E. The new and revised rules proposed for legislative and executive implementation regard: Colorado Senate Bills 21-094, 22-116, and 22-173; Colorado House Bills 22-1284, 22-1235, 22-1246, and 22-1326; and Executive Orders D 2022-032 and D 2022-034.


Joint Stakeholder Meeting - August 29, 2022

The Division of Profession and Occupations held a Joint Stakeholder Meeting for all Healthcare Boards with Prescriptive Authority to allow stakeholders an opportunity to provide feedback on the implementation of Colorado House Bill 22-1115 (Concerning the Prescription Drug Monitoring Program, and, in connection therewith, making an appropriation).


Joint Stakeholder Meeting - October 15, 2021

The State Board of Pharmacy, State Board of Nursing, Colorado Medical Board, Colorado Dental Board, Colorado Podiatry Board, State Board of Veterinary Medicine, and State Board of Optometry held a Joint Stakeholder Meeting to gather feedback to identify and create a list of prescription drugs and substances (using evidence-based practices), in addition to controlled substances, that have a substantial potential for abuse and must require pharmacists and prescription drug outlets to report those prescription drugs and substances to the Prescription Drug Monitoring Program (PDMP) when dispensed to a patient. The Board is considering the development of new rules to monitor non-controlled prescription drugs/substances, as allowed per section 12-280-404(2)(b)(I), C.R.S., of Colorado Senate Bill 21-098.

Rulemaking Hearing - September 30, 2021

he State Board of Pharmacy held a Permanent Rulemaking Hearing on September 30, 2021, that allowed stakeholders a final opportunity to provide feedback before the Board considered adopting new and revised rules that were recommended by the Board and stakeholders to provide clarity and a general cleanup of the rules; and the implementation of Colorado Senate Bill 21-011 (Concerning responsibilities of a pharmacist related to opiate antagonists); Colorado Senate Bill 21-077 (Concerning the elimination of verification of an individual's lawful presence in the United States as a requirement for individual credentialing); Colorado Senate Bill 21-094 (Concerning the continuation of the State Board of Pharmacy, and, in connection therewith, implementing recommendations contained in the 2020 sunset report by the Department of Regulatory Agencies and making other changes regarding the practice of professions regulated by the board); Colorado Senate Bill 21-098 (Concerning the continuation of the prescription drug monitoring program); Colorado Senate Bill 21-122 (Concerning the bulk purchase of opiate antagonists pursuant to a standing order); and Colorado Senate Bill 21-123 (Concerning expanding the Canadian prescription drug importation program to include prescription drug suppliers from nations other than Canada upon the enactment of legislation by the United States congress authorizing such practice). 

Legislative Updates
Meeting Minutes

Board Meeting Minutes

Veterinary Pharmaceutical Advisory Committee (VPAC) Minutes


Open Embed